Surrozen, Inc. Common SRZN
$29.50
-3.81%
at last close
Market Cap$584.62 million
P/E Ratio—
Div Yield—
Volume18.0K
52-Week Range
$11.39$37.83
Analyst Ratings
- Consensus
- Buy — 5 Buy · 0 Hold · 0 Sell (5 analysts)
- Avg. Price Target
- $65.33 (+121.5% upside)
Key Stats
- Today's Range
- $29.36 – $30.34
- 50-Day Range
- $16.14 – $37.83
- 52-Week Range
- $11.39 – $37.83
- Volume
- 18K shs
- Average Volume
- 339K shs
- Market Cap
- $584.62 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.20%
- Days to Cover
- 1.00
About Surrozen, Inc. Common
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
Related Stocks
Compare head-to-head: SRZN vs AMGN·SRZN vs MRNA·SRZN vs RGEN·SRZN vs HALO
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
